Kerrisdale Advisers’s Herbalife HLF Stock Holding History

Kerrisdale Advisers’s Portfolio HLF Stock Details HLF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-34,000	Closed	-$641K	–	31
2014 Q4	$641K	Sell	34,000 -600	-2%	-$12.8K	0.32%	26
2014 Q3	$756K	Hold	34,600	–	–	0.39%	33
2014 Q2	$1.12M	Buy	+34,600	New	+$1.06M	0.53%	23

Other funds holding HLF

Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SFM

Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

RR Partners New York $929M AUM 110.28% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Kerrisdale Advisers's HLF Position: Q4 2014 in Review

Kerrisdale Advisers sold out of Herbalife (HLF) in Q4 2014, closing a stake of 127,176 shares — an estimated $2.72M sold.

Kerrisdale Advisers first reported a position in HLF in Q2 2013 and held it in 6 quarters. The position peaked at $17.1M in Q2 2014. 242 funds tracked by Wall St. Rank hold HLF as of Q4 2014.

Kerrisdale Advisers reported no remaining Herbalife position as of Q4 2014 after selling out during the quarter.
Kerrisdale Advisers sold 127,176 Herbalife shares in Q4 2014, an estimated $2.72M.
Kerrisdale Advisers first reported a position in Herbalife in Q2 2013 and held it in 6 quarters.
Kerrisdale Advisers's Herbalife position peaked at $17.1M in Q2 2014.
242 funds tracked by Wall St. Rank held Herbalife as of Q4 2014.

Based on Kerrisdale Advisers's 13F filing for Q4 2014, filed 17 Feb 2015.